Show simple item record

dc.contributor.authorTengvall, Sara
dc.date.accessioned2007-08-22T08:21:54Z
dc.date.available2007-08-22T08:21:54Z
dc.date.issued2007-08-22T08:21:54Z
dc.identifier.isbn978-91-628-7204-5
dc.identifier.urihttp://hdl.handle.net/2077/4708
dc.description.abstractDevelopment of mucosal vaccines for inducing immunity in the female reproductive tract would have profound implications for the prevention of sexually transmitted diseases. Despite numerous efforts, no such vaccines are currently available for human use. The main objective of this doctoral thesis was to develop novel immunization approaches to generate immunity in the female genital tract with special emphasis on immunity against genital herpes. Mammalian innate immune systems sense and respond to pathogens through a series of pattern recognition receptors such as Toll-like receptors (TLRs). Detection of pathogen associated molecular patterns by TLRs triggers a signaling pathway mainly through adaptor protein MyD88, which results in a coordinated set of immune responses that includes both innate and acquired immunity. By using a well-established mouse model of genital HSV-2 infection, it was shown in this thesis that the efficacy of intramuscular immunization with a DNA vaccine encoding glycoprotein D (gD) from HSV-2 can be improved with a timely administration of synthetic oligodeoxynucleotide (ODN) containing immunostimulatory CpG motifs, a TLR9 ligand. Another important finding in this thesis work was introduction of CpG ODN as a potent vaginal adjuvant for induction of acquired immunity in the female genital tract as well as for systemic immune response. Thus, vaginal immunization with HSV-2 gD in combination with CpG ODN induced a potent gD specific antibody as well as cellular immunity, and conferred protection against subsequent vaginal challenge with a lethal dose of HSV-2. The potential of rectal immunization route to induce protective immunity in the female genital tract was also investigated. Thus, rectal immunization with a live attenuated HSV-2 TK- was shown to confer antibody and cellular response as well as protection against an otherwise lethal vaginal challenge with a virulent HSV-2 strain. Importantly, unlike intravaginal route, rectal route was shown to be independent of sex hormonal influence. It was also documented that TLR/MyD88 signaling pathway is important for innate immune protection against primary genital herpes. By contrast, the usage of MyD88 was shown to be dispensable for induction of acquired immune protection induced by vaginal or rectal immunization with HSV-2 TK-. In addition, while rectal immunization with the TLR/MyD88 targeting adjuvant CpG ODN in combination with gD failed to elicit protective immunity, rectal immunization with cholera toxin and gD conferred a potent antibody and cellular immune responses as well as protection against genital herpes. These results have implications for the development of vaccines to generate immunity in the female genital tract against sexually transmitted infections.eng
dc.language.isoengeng
dc.relation.haspartI) Tengvall S, Josefsson A, Holmgren J, Harandi AM. CpG Oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice. Journal of Reproductive Immunology 2005 Dec;68(1-2):53-69. ::PMID::16229896eng
dc.relation.haspartII) Tengvall S, Lundqvist A, Eisenberg RJ, Cohen GH, Harandi AM. Mucosal administration of CpG Oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes. Journal of Virology 2006 Jun;80(11):5283-91. ::PMID::16699008eng
dc.relation.haspartIII) Tengvall S, O'Hagan D, Harandi AM. Rectal immunization confers a sex hormonal- and MyD88- independent protective immunity against genital herpes simplex virus type 2 infection in mice. Submitted for publicationeng
dc.relation.haspartIV) Tengvall S, Harandi AM. Importance of the adaptor molecule MyD88 in innate and adaptive immune protection against genital herpes infection in mice. Manuscripteng
dc.subjectfemale genital tract immunityeng
dc.subjectgenital herpeseng
dc.subjectmucosal adjuvanteng
dc.subjectTLReng
dc.subjectMyD88eng
dc.subjectCpG ODNeng
dc.titleDevelopment of novel immunization approaches to generate immunity in the female genital tract with special reference to genital herpeseng
dc.typetexteng
dc.type.svepDoctoral thesiseng
dc.gup.mailsara.tengvall@microbio.gu.seeng
dc.type.degreeDoctor of Philosophy (Medicine)eng
dc.gup.defenceTisdagen den 12 juni 2007, kl. 09.00. Hörsal ”Arvid Carlsson”, Academicumeng
dc.gup.originGöteborg University. Sahlgrenska Academyeng
dc.gup.departmentInst of Biomedicine. Dept of Medical Microbiology and Immunologyeng
dc.gup.dissdb-fakultetSA


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record